Himesh B. Zaver

Himesh B. Zaver


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in Clinical Liver Disease
Verified
Journal Article
Closed access
HZHimesh Zaver
Himesh Zaver
TPTushar Patel
Tushar Patel
Export

20 November 2020 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
HZHimesh Zaver
Himesh Zaver
HGHassan Ghoz
Hassan Ghoz
BMBalkishan J. Malviya
Balkishan J. Malviya
BBBhaumik Brahmbhatt
Bhaumik Brahmbhatt
WPWilliam C. Palmer
William C. Palmer
YBYan Bi
Yan Bi

6 April 2023 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
HZHimesh Zaver
Himesh Zaver
OMObaie Mzaik
Obaie Mzaik
JTJonathan Thomas
Jonathan Thomas
JRJoanna Roopkumar
Joanna Roopkumar
DADemilade Adedinsewo
Demilade Adedinsewo
TPTushar Patel
Tushar Patel

16 March 2021 in JMIR Cancer
Verified
Journal Article
Open access
SOSven P Oman
Sven P Oman
HZHimesh Zaver
Himesh Zaver
MWMark Waddle
Mark Waddle
JCJuan E Corral
Juan E Corral
Background: Pancreatic cysts are a complex medical problem with several treatment options. Patients use web-based health information to understand their conditions and to guide treatment choices. Objective: The goal of this study was to describe the quality and readability of publicly available web-based information on pancreatic cysts and to compare this information across website affiliations. Methods: A Google search for “pancreatic cysts” was performed and the first 30 websites were evaluated. Website affiliations were classified as academic, media, nonprofit, government, or not disclosed. Information describing cancer risk was recorded. The DISCERN instrument measured the quality of content regarding treatment choices. Four standardized tests were used to measure readability. Results: Twenty-one websites were included. The majority of the websites (20/21, 95%) described the cancer risk associated with pancreatic cysts. Nearly half of the websites were written by an academic hospital or organization. The average DISCERN score for all websites was 40.4 (range 26-65.5, maximum 80). Websites received low scores due to lack of references, failure to describe the risks of treatment, or lack of details on how treatment choices affect quality of life. The average readability score was 14.74 (range 5.76-23.85, maximum 19+), indicating a college reading level. There were no significant differences across website affiliation groups. Conclusions: Web-based information for patients with pancreatic cysts is of moderate quality and is written above the reading level of most Americans. Gastroenterological, cancer treatment organizations, and physicians should advocate for improving the available information by providing cancer risk stratification, treatment impact on quality of life, references, and better readability.

10 November 2021 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
HZHimesh Zaver
Himesh Zaver
VMVarun P. Moktan
Varun P. Moktan
EHEugene P. Harper
Eugene P. Harper
ABAman Bali
Aman Bali
ANAyan Nasir
Ayan Nasir
WBWendelyn Bosch
Wendelyn Bosch
To reduce health care facility–onset (HCFO) Clostridioides difficile infection (CDI) incidence by improving diagnostic stewardship and reducing the inappropriate testing of C difficile assays. A multidisciplinary team conducted a quality improvement initiative from January 1, 2020, through March 31, 2021. Clostridioides difficile infection and inappropriate testing were identified via electronic health records using predefined criteria related to stool quantity/caliber, confounding medications, and laboratory data. An intervention bundle was designed including (1) provider education, (2) implementation of an appropriate testing algorithm, (3) expert review of C difficile orders, and (4) batch testing of assays to facilitate review and cancellation if inappropriate. Compared with a baseline period from January to September 2020, implementation of our intervention bundle from December 2020 to March 2021 resulted in an 83.6% reduction in inappropriate orders tested and a 41.7% reduction in HCFO CDI incidence. A novel prevention bundle improved C difficile diagnostic stewardship and HCFO CDI incidence by reducing testing of inappropriate orders. Such initiatives targeting HCFO CDI may positively affect patient safety and hospital reimbursement.

1 February 2021 in ACG Case Reports Journal
Verified
Journal Article
Open access
HZHimesh Zaver
Himesh Zaver
KAKhaled I. Alnahhal
Khaled I. Alnahhal
HGHassan Ghoz
Hassan Ghoz
RPRicardo Paz-Fumagalli
Ricardo Paz-Fumagalli
MRMassimo Raimondo
Massimo Raimondo
FLFrank J. Lukens
Frank J. Lukens
Insulinomas are rare, with an annual incidence of 1–4 people per mission. Insulinomas are the most common functioning endocrine neoplams of the pancreas. Endoscopic ultrasound has both diagnostic and therapeutic yield in undifferentiated pancreatic tumors. We present a case of a recurrent insulinoma, refractory to surgical and medical management diagnosed with endoscopic ultrasound. Our case uniquely conveys a successful, alternative approach to addressing symptomatic insulinomas refractory to surgical or medical management through computed tomography–guided percutaneous ethanol-lipiodol injection.